Ralf Kuriyel, Senior VP, R&D at REPLIGEN CORP (RGEN), sold 8,930 shares at $165.67 ($1.5M) on 2024-08-01, disclosed to the SEC on 2024-08-01.
Open-market sale of $1.5M RGEN by Senior VP, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $165.67 | 4,465 | $740K | 50.0% |
| 2 | $165.67 | 4,465 | $740K | 50.0% |
| Total | $165.67 avg | 8,930 | $1.5M | 100% |
| Filing → |
| RGEN | SELL | 2022-08-12 | $2.3M | — | Filing → |
| RGEN | SELL | 2021-09-02 | $2.3M | — | Filing → |
| RGEN | SELL | 2021-06-14 | $2.6M | — | Filing → |